Public limited company
Business purpose, research and financing of aimeim
SAS Uruguay
The aimeim cell rejuvenation app revolutionises the
global health market
aimeim - the social network for health and cell rejuvenation
aimeim SAS Uruguay RN° ......................................................................is by licence
agreement the global and exclusive rights user of the aimeim distribution or operating
licences.
Aimeim.info will be developed as a free internet portal and social network offering for
human health and cell rejuvenation through information. For this, two app steps - GenClean
and aimeim - have to be developed for an app software.
Raising capital and funding for research and software development as well as the
implementation of the worldwide exclusive licences for cell regeneration (GenClean) and
cell rejuvenation (aimeim) by providing information for the social network and internet
portal of aimeim SAS.
Also to be funded is research into the effect of materialised and non-materialised information
according to Dieter W. Liedtke's information theory and to reformat the epigenetic and
genetic programme structures of the DNA through information, as well as to stimulate the
gene programmes in a natural way for the recovery of the body's cells or to install new
programme interfaces in the gene programmes that enable the body's cells to reverse the
ageing process in a controlled manner if necessary through targeted new, non-materialised
information:ele of aimeim:
1. Purification of genes, gene programmes and DNA
2. Reduction of depression and illness
3. Anti-addiction programmes
4. Neuro- and -biological control programmes for the application objectives 1. to 3.
5. Switching DNA for cell rejuvenation through new gene programme interfaces (meta-
interfaces)
6. Food development
7. Software development
8. Biological control programmes to determine the gained lifespan through examinations
of the DNA (before and after the application of aimeim). Determination of the
biological age of the cells and measurement of the length of the telomeres and / or the
structure and biological condition of the muscles and skin structure.
The Company has a share capital of US $1,000.
............. ordinary shares with voting rights will be issued.
The confirmation of participation is sent to the shareholder or his trustee by e-mail. The
shareholders participate in the dividend distributions of the Company. The holders of the
shares or their trustees shall be recorded as shareholders in the share register at the registered
office of the Company or at the registered office of the trustee. The shareholders or their
trustees shall be entered in the competent commercial register at the registered office of the
Company upon request and against reimbursement of costs. Information on the Company as
well as invitations to shareholders' meetings shall be communicated to the shareholder or the
trustee exclusively by e-mail. To the extent legally permissible, resolutions to increase the
capital shall become legally effective with 75 % and one share of the share capital
represented and appropriation of funds
The sale of aimeim crypto aimeim Long Life Coins (LLC) will raise further funds for the
research, programming and global marketing of the aimeim health and cell rejuvenation app
through the ........... Trust in Uruguay, which has already acquired a 50% block of shares in
aimeim SAS in Uruguay for this purpose, which are allocated in proportionate ownership to
the aimeim LL Coin owners and participate pro rata in the annual results with their coins of
the 50% block of shares. (see also Holdings LL Coin)
The company is a start-up and has no extraordinary liabilities.Capital requirements
The capital requirement of the company is calculated in several steps at approx. 100 million
US $.IPO
It is envisaged that the Company's shares will be traded on a stock exchange in the medium
term - following successful aimeim tests in the global application.Yield
Yield forecasts cannot be made at present without the test evaluations.
The first business models will be developed after the aimeim tests have been completed.